Hims Zepbound Cost: Lilly Deal, Foundayo Prices, How It Works

Does Hims sell Zepbound now, and what does it cost? Yes. On November 6, 2026, Eli Lilly and Hims & Hers announced a deal that lets eligible patients get Zepbound (tirzepatide) from $299 a month and the Foundayo (orforglipron) pill from $149 a month on the Hims & Hers platform. Those starting prices match LillyDirect. You still need a prescription from a licensed provider, and higher doses cost more.

Before this, Reuters reports, Hims patients had to leave the site and buy through LillyDirect. The change is about convenience. It is not a price cut.

How much does Hims Zepbound cost without insurance?

The release gives only the starting prices. Reuters reports they match LillyDirect, so the table below uses Lilly's own list, which we checked on November 6, 2026. Treat it as a guide until you see your dose priced in the Hims app.

The refill rule is the trap. On Lilly's list, a late refill at 10 mg or higher raises that fill by $250. Our LillyDirect Zepbound guide covers the KwikPen, vials and needles in full. Remember that a Zepbound "month" on LillyDirect is 28 days, so a year means about 13 fills. At $449, that is about $5,837 a year before needles.

What we could not confirm yet

This deal is hours old, and the release leaves real gaps. Here is what is still open as of today:

• Start date. No date is given. The release refers to a rollout still to come.
• Membership fee. The release describes a weight loss membership with 24/7 care team access, nutrition guidance and check-ins, but it does not state a price. Hims blocked our price check, so we will not guess. Ask for the total monthly cost, including medicine and membership, before you pay.
• Pen or vial. The new release does not say which Zepbound forms are included. An April 2026 report said Hims providers could already send Zepbound vial, KwikPen and Foundayo prescriptions to LillyDirect Pharmacy.
• The 45-day rule. The release says the prices are the same as for any patient, but it does not spell out how the refill rule works on Hims.

We will update this page as these facts land.

Is Hims Zepbound compounded or the real thing?

It is the real thing. The deal covers FDA-approved Zepbound and Foundayo made by Lilly. The joint release says Hims has never offered compounded copies of Lilly's GLP-1 drugs and has committed not to. So a "Hims tirzepatide" offer that is not Lilly's brand would not be part of this deal.

This matters because of how Hims got here. In February 2026 it launched a compounded semaglutide pill at $49, and Novo Nordisk sued. In March, the two made a deal: Novo dropped the suit, though it kept the right to refile, and Hims began offering Ozempic and Wegovy. Hims said it would stop advertising compounded GLP-1s and move patients to approved drugs when a provider judged that right, while a limited number of patients could stay on compounded versions. The FDA does not review compounded drugs for safety or quality before they are sold, as our compounded GLP-1 guide explains.

How do you get Zepbound through Hims?

The release lays out three steps:

1. Do a consultation with a licensed provider on the platform.
2. Get a prescription, if the provider decides it fits you. A "no" is possible. Both companies say providers stay free to choose the treatment they think is right.
3. Get it shipped to your home.

Zepbound is for adults with obesity or with overweight plus a weight-related health problem, and for adults with obesity and moderate to severe sleep apnea. Foundayo is for adults with obesity or with overweight plus a weight-related problem. Both carry a boxed warning about thyroid C-cell tumors. Tell the provider your full history. If you are pregnant, under 18, or have had an eating disorder, talk with your own doctor first.

Hims vs LillyDirect: which should you use?

The medicine price is the same, so compare what surrounds it.

One real perk of Hims is choice in one place. Reuters says Hims lists the Wegovy pill from $149 a month and the Wegovy pen from $199. If you are torn between pills, our Wegovy pill vs Foundayo guide compares them. For a price check across routes, see TrumpRx GLP-1 prices.

Zepbound or Foundayo: what does the price buy?

These results come from separate trials, not head-to-head testing, and people differ.

Our Foundayo guide goes through the label in detail. Your prescriber can help you weigh shot against pill.

Can you use insurance or Medicare?

The release describes self-pay prices only and does not mention insurance. Off Hims, Lilly's savings card can bring the cost as low as $25 a month for eligible people with commercial coverage, and government beneficiaries are excluded. Eligible Medicare Part D patients can look at the Medicare GLP-1 Bridge, but we could not confirm that it works on Hims. Check your coverage before paying cash.

What to do once the medicine ships

At up to $449 a fill, you want the weight you lose to be fat, not muscle. Part of the weight lost on these drugs is lean mass. Protein and strength training are the two habits that help most, and neither comes in the box. Set your number with our protein target guide, then build the routine with our resistance training guide. Sharpy turns that into one daily protein target, one 20-minute workout and a Shape Score, so you can see your shape change, not only the scale.

The bottom line

The new deal gives Hims patients a way to buy brand-name Zepbound from $299 and Foundayo from $149 without leaving the platform. The drug prices match LillyDirect, so the deal saves steps, not money. Before you sign up, find out the membership fee, the price at your dose and the refill rules. Do not change or stop a dose without your prescriber. And while the drug handles appetite, Sharpy can help you keep the muscle.

Sources

• Hims & Hers newsroom: Lilly and Hims & Hers expand access to FDA-approved Lilly medicines (Nov 6, 2026)
• Reuters via Yahoo Finance: Lilly to sell obesity drugs directly on Hims & Hers site (Nov 6, 2026)
• LillyDirect: Zepbound self-pay prices, checked Nov 6, 2026
• LillyDirect: Foundayo self-pay prices, checked Nov 6, 2026
• Hims & Hers 8-K press release on the Novo Nordisk agreement (Mar 9, 2026)
• Securities.io: Lilly and Hims & Hers formalize self-pay access (Nov 6, 2026)
• NEJM: SURMOUNT-1, tirzepatide once weekly for obesity
• FDA: Concerns with unapproved GLP-1 drugs used for weight loss